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ABSTRACT. Four feline renal cell carcinomas (RCCs) were examined using histopathological and immunohistochemical procedures. Speci-
mens were classified by predominant histological pattern according to WHO criteria. A panel of antibodies including β-catenin, C-KIT, 
VEGF and VEGF-R2 and double immunostaining for vimentin/cytokeratin and for E-cadherin/CD10 was selected to characterize the 
tumors. Neoplasms were classified as tubular (3/4) and papillary (1/4). Neoplastic epithelial cells were cytokeratin, vimentin, E-cadherin, 
VEGF-R2 positive and C-KIT negative; 3 cases were β-catenin positive, whereas only 2 tumors were CD10 and VEGF positive. No correla-
tion with histotype was evident. Our results confirm the low frequency of RCCs in cats and suggest a histological pattern similar to canine 
RCCs. In contrast, a peculiar immunohistochemical profile different from both canine and human RCCs is identified.
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The prevalence of primary renal tumors (RT) in domestic 
animals is less than 1% of the total neoplasms reported. Ex-
cept for lymphoma, other primary RT in cats are extremely 
rare [27] and only few case reports [13, 27], and surveys of 
feline tumors [15] are described. Based on the data available, 
feline renal cell carcinomas (RCCs) show no breed predi-
lection, occur in older cats, unilaterally, and metastasize 
sporadically [27].
In dogs, RT account for 0.6–1.7% of neoplasms, and RCC 
is the most frequent subtype, accounting for 60–85% [23] 
and being more common in male middle-aged dogs with-
out breed predilection [4]. RCCs are classified on the pre-
dominant histologic pattern, like papillary, tubular or solid 
[12], but a mixture of all types is often present [23]. These 
histologic types can be further classified as chromophobic, 
eosinophilic or clear cell variants, and generally, all the 3 
cell types are present [12]. Immunohistochemical features of 
RCCs were extensively analyzed only in dogs. No correla-
tion between immunohistochemical profile and biological 
behavior was found [12], but mitotic index was identified as 
the best predictor of survival [9, 12]. In human, more than 
90% of the RT arise from the renal tubules [29], and RCC 
is the most common one, representing approximately 2–3% 
of all cancers worldwide [1] and is classified into 8 different 
histological subtypes [29].
The diagnosis is usually based on morphological analysis; 
however, ancillary techniques, such as immunohistochemis-
try, electron microscopy, cytogenetics and molecular genet-
ics, have proved to be useful in refining RCCs classifica-
tion and offer biological data [28]. Some studies have also 
suggested the use of immunohistochemistry in combination 
with histopathology to define RCCs origin and classification, 
to differentiate renal cell neoplasms from non-renal tumors 
and to correctly identify metastatic RCCs in distant organs, 
especially when only small biopsy specimens are available 
[20, 29].
The purposes of this study are to describe the histological 
features and the immunohistochemical profile in four feline 
RCCs and to evaluate a possible correlation between histo-
logic pattern and immunohistochemical profile.
Four cases of RCC diagnosed between October 2005 and 
February 2014 were retrieved from the archive of the Histo-
pathology Services, Department of Comparative Biomedi-
cine and Food Science, University of Padua. All specimens 
were obtained by nephrectomy. Tumor samples were fixed 
in 10% neutral buffered formalin and processed routinely. 
Serial 3 µm thick sections for each tumor were stained with 
hematoxylin-eosin and Periodic Acid Schiff (PAS). The 
specimens were evaluated by light microscopy for the di-
agnoses of RCC. Tumors were classified by predominant 
histologic pattern according to World Health Organization 
(WHO) criteria [23]. The presence or absence of necrosis, 
nuclear pleomorphism (slight to marked) and mitotic index 
(mitotic figures per 10 high-power fields) were also scored. 
Regional lymph nodes were not available for evaluation.
For immunohistochemistry (IHC), serial paraffin sec-
tions were processed as previously described [30] using an 
automatic immunostainer (Ventana Benchmark XT, Ventana 
Medical Systems Inc., Tucson, AZ, U.S.A.).
All the antibodies (Abs) used in this work were previ-
ously tested in cat [7, 18, 24, 25, 30]. The following markers 
were assessed by IHC: cytokeratins (CKs), vimentin (VIM), 
CD10, E-cadherin (E-CAD), β-catenin (β-CAT), C-KIT, 
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vascular endothelial growth factor (VEGF) and vascular en-
dothelial growth factor receptor 2 (VEGF-R2). Double im-
munolabelings (using DAB and Red detection kit) for VIM/
CKs and for E-CAD/CD10 were also performed to evaluate 
the co-expression of these antigens. The same Abs panel was 
employed in normal renal samples to define the IHC profile. 
The immunoreactivity for each marker was assessed semi-
quantitatively (Table 1). In Table S1 are reported sources, 
clones and dilution for each antibody.
All the cats described in this report were male, ranged 
from 9 to 12 years (median age: 10.5 years). The referring 
veterinarians reported no other neoplastic lesions identified 
during clinical examination. The tumors were classified as 
tubular (n=3) and papillary (n=1) RCCs.
In tubular RCCs, neoplastic cells were arranged in mono-
layer forming irregular tubules often distended by intralu-
minal homogenous, eosinophilic, PAS-positive material. Fo-
cally, cells were arranged in multilayer lining papillae with 
fibrovascular core. Cells were 30–40 µm in size, cuboidal to 
columnar, with indistinct cell borders and moderate amount 
of eosinophilic amorphous cytoplasm. Nuclei were round to 
oval, 25–30 µm, centrally located with marginated chroma-
tin and prominent, single round nucleolus. Anisocytosis and 
anisokaryosis were moderate. Mitoses were 4 to 5 per 10 
higher-power fields (HPF) (Fig. 1A).
The papillary RCC was poorly defined and composed of 
neoplastic cells lining irregular papillae or tubular structures 
associated with moderate fibrovascular stroma. Neoplastic 
cells were columnar to polygonal, with indistinct cell borders 
and moderate eosinophilic cytoplasm. Nuclei were round, 
central, with granular chromatin and single, prominent 
nucleolus. Anisocytosis and anisokaryosis were moderate. 
Multifocal necrotic areas with mineralizations and moderate 
neutrophilic inflammation were present. Adjacent renal tis-
sue was compressed with moderate glomerular and tubular 
atrophy. Mitoses were 5 per 10 HPF (Fig. 1B).
Table 1 shows immunohistochemistry results. In normal 
kidney, VIM was detected in endothelial glomerular cells, 
while cells at the urinary pole of the Bowman’s capsule 
were CD10 positive. All the other glomerular cells were 
completely negative. Proximal and distal tubular epithelial 
cells (TECs) expressed CKs and β-CAT. Moreover, proximal 
TECs were positive for CD10 and negative for E-CAD, and 
vice versa, distal TECs were positive for E-CAD and nega-
tive for CD10 (Fig. 2 A-C). C-KIT was detected neither in 
glomerular nor in TECs.
Table 1. Histologic and Immunohistochemical features of 4 feline Renal Cell Carcinomas and normal feline kidney
No. Histologic Pattern Mitotic index Vim panCK CD10 E-cad β -cat c-KIT VEGF VEGF-R2
1 RCC tubular 5/10HPF ++ + – + – – – +
2 RCC tubular 4/10HPF + + – + + – – +
3 RCC tubular 4/10HPF ++ + + ++ ++ – + +
4 RCC papillary 5/10HPF + + + ++ ++ – + +
Control Proximal tubule – + + – + – +/– –
Control Distal tubule – + – + + – +/– –
Control Glomerulus + a) –a) +a) –a) –a) –a) –a) –a)
Scoring: –, negative; +/–, weak; +, moderate; ++, strong. a) Positivity to VIM is detected in endothelial glomerular cells, while positivity to CD10 
is at the urinary pole of the Bowman’s capsule. All the other glomerular cells showed negative for the other markers. Mitotic index : mitotic figures 
per 10 high-power fields (HPF).
Fig. 1. Histological features of tubular and papillary RCCs. A) tubular RCC: neoplastic cells were arranged in monolayer forming 
irregular tubules often distended by intraluminal homogenous, eosinophilic material (proteinaceous material) and separated 
by variably thickened septa of fibrovascular stroma. Anisocytosis and anisokaryosis were moderate. 200× magnification, He-
matoxylin and eosin (HE). B) papillary RCC: neoplastic cells formed irregular papillae or tubular structures associated with 
moderate fibrovascular stroma. Anisocytosis and anisokaryosis were moderate. 200× magnification, HE.
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All the RCCs were positive for CKs, VIM and E-CAD. 
Neoplastic ECs in 2 tumors were CD10 positive, while posi-
tivity to β-CAT was recorded in neoplastic ECs in 3 tumors, 
but without nuclear positivity. VEGF-R2 was expressed by 
ECs in all tumor samples, whereas VEGF was expressed only 
in 2 cases. None of the specimens expressed C-KIT. Double 
IHC analysis showed for all the cases the co-expression of 
VIM and CKs within neoplastic ECs, whereas co-expression 
of E-CAD and CD10 was detected in 2 cases and the other 2 
were E-CAD positive and CD10 negative (Fig. 2 D–I).
Fig. 2. Immunohistochemical results in normal kidney and in neoplastic samples. A) normal kidney, double IHC VIM (brown) /CK (red): 
proximal and distal tubular epithelial cells were positive for panCK. B) normal kidney, double IHC E-CAD (brown) /CD10 (red): proximal 
tubular ECs were positive for CD10 and negative for E-CAD, and opposite pattern expression was present on distal tubular ECs. C) normal 
kidney, IHC VEGF (brown). Low expression was evident on tubular epithelial cells. D) RCC tubular, double IHC VIM (brown)/CK (red): 
neoplastic cells were positive for CK and VIM. The positivity to these markers was always localized in the cytoplasm. E) RCC tubular, 
double IHC E-CAD (brown)/CD10 (red): the expression of E-CAD on the membrane and the negativity to CD10 could reflect the distal tu-
bule origin of the neoplasm. F) RCC tubular, IHC VEGF (brown). No expression was evident on neoplastic cells. G) RCC papillary, double 
IHC VIM (brown)/CK (red). H) RCC papillary, double IHC E-CAD (brown)/CD10 (red). I) RCC papillary, IHC VEGF (brown). A strong 
and diffuse immunoreactivity for VIM, CK, E-CAD and CD10 was evident on neoplastic cells. Also, VEGF showed higher expression 
compared to normal kidney. Double immunostaining for CK and vimentin and counterstaining with Periodic Acid Schiff (PAS); Double 
immunostaining for CD10 and E-CAD, single immunostaining for VEGF and counterstaining with hematoxylin. 400× magnification.
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In this case series, the histological and immunohisto-
chemical features of a small series of feline RCCs are de-
scribed. Our results identify the co-expression of CKs and 
VIM and no expression of C-KIT as a common finding in 
all the RCCs. However, no correlation with histotype was 
clearly evident.
RCCs are rare in cats, as confirmed by the small number of 
cases in our database including approximately 11,000 cases 
in a spanning period of 9 years. Tubular RCC is considered 
the most common variety in domestic animals. However, 
recently, solid and papillary were reported to be the predomi-
nant subtypes in dogs [9, 12]. In our study, tubular subtype 
was seen in 3 out of 4 of the tumors, and except for sample 1, 
all tumors had a mixture of histologic pattern, in accordance 
with previous reports [23]. All tumors showed low mitotic 
index and slight to moderate nuclear atypia. Apparently, 
this morphology is suggestive of low-grade neoplasms, but 
unfortunately, the lack of follow-up data prevents any cor-
relation with biological behavior.
There is a paucity of literature on feline RCC, particularly 
focusing on protein expression profile. We included in our 
panel five antibodies (CKs, VIM, CD10, E-CAD and C-KIT) 
which are used in human medicine as a helpful combination 
for the diagnosis and classification of RCC [2, 5].
All tumors co-expressed VIM and CKs, while in normal 
kidney, these markers were differently expressed in the 
nephron, with endothelial cells positive to VIM and tubu-
lar cells positive to CKs. These findings are similar with 
those previously reported in human in which co-expression 
of these molecules is widely known in RCCs, particularly 
tubulopapillary and clear cell subtypes. In contrast, this 
phenotype was recorded occasionally in canine RCCs [12] 
(Table 2). Some authors proposed that VIM and CKs ex-
pression by ECs demonstrates the origin from remnants of 
embryonic mesenchyme [14], but could also be associated 
with undifferentiated renal stem cells or an acquired epithe-
lial–mesenchymal transition (EMT) associated with an inva-
sive phenotype [8]. The co-expression of the two proteins in 
TECs was reported during EMT in chronic renal damage [3] 
and interpreted as an intermediate step in this process [6]. 
However, during EMT, co-localization was seen in scattered 
cells [6], whereas in feline RCCs, the majority of the cells 
co-express VIM and CKs. Indeed, this might be considered 
a critical step in the neoplastic process already described in 
other feline tumors, such as skin adnexal, thyroid, pulmonary 
and mammary carcinomas [21, 22]. Also, this immunohisto-
chemical profile might be useful to differentiate RCCs from 
unknown primary cancer localized in the kidney. C-KIT, a 
transmembrane tyrosine kinase growth factor [11], is com-
monly used to identify chromophobe RCC and oncocytoma 
in human [29], however none of our tumors expressed this 
protein, being more similar to human clear cell and papillary 
RCCs [19]. This also differentiates from dog where C-KIT is 
expressed in the majority of the RCCs [12].
E-CAD in normal human kidney is expressed in renal 
tubular cells, and the kidney specific isoform is expressed 
exclusively in the renal distal convoluted and collecting 
duct cells [29]; instead, CD10 is detected on brush border of 
proximal convoluted tubule [17]. In our study, double IHC 
analysis confirmed this pattern in feline kidney. In human 
medicine, RCCs with proximal tubular differentiation ex-
press CD10, whereas those with distal tubular differentiation 
express kidney-specific cadherin. Additionally, it has been 
proposed that, while conventional RCCs are closely related 
to mature proximal ECs, papillary subtype is more similar 
to embryonal proximal tubular cells [16]. In our cases, 2 tu-
bular RCCs were E-CAD positive and CD10 negative, con-
firming the distal convoluted tubule origin. The other 2 cases 
expressed both E-CAD and CD10: if we could assume an 
embryonal proximal tubular cells origin for papillary RCCs, 
we could not identify the tubular segment of origin for the 
tubular ones. Moreover, the use of a monoclonal antibody 
against E-CAD, a molecule expressed in several different 
subtypes of RCC [29], limits the possibility to correctly 
define the origin of the neoplasm.
VEGF and its receptors are essential in physiological 
and pathological angiogenesis by stimulating endothelial 
cells to form new vessels [10]. In our study, normal kidney 
was negative to VEGF-R2 and slightly positive to VEGF, 
determining a low angiogenic activity. On the contrary, 
the expression of VEGF-R2 was total in our samples and 
variable for VEGF. This could reflect a variable angiogenic 
activity among tumor.
In conclusion, we confirm the low frequency of feline 
RCCs. Furthermore, even if restricted by the low number 
of cases, feline RCC seems to have an histological pattern 
similar to canine RCC, but a different immunohistochemical 
profile compared to human and canine RCC. In particular, 
the co-expression of VIM and CKs and the negativity to C-
KIT could be useful in the diagnostic approach to feline RT. 
Table 2. Immunoprofile of the major renal neoplasms in human and dogs [26, 28, 29] compared to results obtained on 4 cases of feline renal cell 
carcinoma
Human clear 
cell
Human 
papillary
Human  
chromophobe
Canine tubular-
papillary (n=3)
Canine papillary 
(n=4)
Canine solid 
(n=3)
Feline tubular 
(n=3)
Feline papillary 
(n=1)
panCk + 
(CK8, CK18)
+ 
(CK7, CK8, CK18)
+ +/– +/– – + +
Vimentin + + – + +/– + + +
CD10 + + +/– +/– – +/– +/– +
E-cadherin +/– + + nd nd nd + +
C-kit +/– +/– + + + + – –
Scoring: –, negative; +/–, weak; +, moderate; ++, strong. nd: not determined.
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However, the small number of cases included and the lack of 
clinical information are a limitation, and studies, including 
clinical data, are necessary to define the prognostic signifi-
cance of histological and immunophenotypical features.
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